1 evolution-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"University-of-Southampton" positions at Université de Bordeaux in France

DÉVELOPPEMENT DE NANOBODIES THÉRAPEUTIQUES CIBLANT LE RÉCEPTEUR GUANYLYL CYCLASE C // DEVELOPMENT OF THERAPEUTIC NANOBODIES TARGETING THE GUANYLYL CYCLASE C RECEPTOR.

Université de Bordeaux | Pessac, Aquitaine | France | about 8 hours ago

into GC-C that could pave the way for new drug development. The project will use a combination of biophysical techniques, structural biology, and cell biology to assess the therapeutic potential and